$-3.14
(Market cap
$4 Mln
Recently Viewed
Clear AllMarket cap
$4 Mln
Revenue (TTM)
$140 Mln
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-16 Mln
ROE
-0.3 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
-0.2
Debt to Equity
0.4
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
1,894,710
CFO
$-58.24 Mln
EBITDA
$-109.32 Mln
Net Profit
$-76.66 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medigus - ADR (MDGS)
| -80.1 | -66.0 | -76.0 | -86.7 | -71.1 | -55.2 | -- |
|
BSE Sensex*
| -6.4 | 6.4 | -3.5 | 0.9 | 10.0 | 10.7 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Medigus - ADR (MDGS)
| -30.2 | -68.9 | -47.6 | 9.8 | -33.1 | -50.6 | -76.6 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic... Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. Read more
Chief Executive Officer
Mr. Liron Carmel
Chief Executive Officer
Mr. Liron Carmel
Headquarters
Tel Aviv
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Medigus Ltd - ADR (MDGS) is $1.73 (NASDAQ) as of 18-Jun-2024 09:30 EDT. Medigus Ltd - ADR (MDGS) has given a return of -71.09% in the last 3 years.
Since, TTM earnings of Medigus Ltd - ADR (MDGS) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
The 52-week high and low of Medigus Ltd - ADR (MDGS) are Rs -- and Rs -- as of 22-Apr-2026.
Medigus Ltd - ADR (MDGS) has a market capitalisation of $ 4 Mln as on 18-Jun-2024. As per SEBI classification, it is a Small Cap company.
Before investing in Medigus Ltd - ADR (MDGS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.